Benzoxazole derivatives demonstrated anti-metastatic potential via reduced expression levels of FGF-1, FGF-2, VEGF, and MMP-3 in a fibrosarcoma derived cell line. This evidence concerns the gene FGF1 and fibrosarcoma.